ATROPINE SULFATE
CLASS:
Parasympatholytic
Anticholinergic (vagolytic)
Antimuscarinic
ACTIONS:
An acetylcholine (Ach) antagonist that inhibits the action of ACh by competing with ACh for binding sites on muscarinic receptors, which are located on exocrine glands, cardiac and smooth muscle ganglia
Blocks effects of parasympathetic innervation to the heart which enhances both sinus node automaticity and AV conduction
Relaxes smooth muscle in bronchial tree = bronchodilation
Inhibits glandular secretion in respiratory tract
Inhibits secretions from sweat and salivary glands
Decreases gastrointestinal motility
INDICATIONS:
Symptomatic bradyarrhythmias
Symptomatic conduction defects, ie. Stokes-Adams syndrome
Organophosphate (cholinergic) poisoning
Status asthmaticus (aerosol nebulizer route)
CONTRAINDICATION:
Tachycardia
Acute narrow-angle glaucoma
Acute MI
Myasthenia gravis
Obstructive disease of the GI tract
Hypersensitivity
STANDARD PREPS:
1 mg / 10 cc preloaded syringe
1mg / 1 cc vial
DOSAGES/ROUTES:
0.5 to 1.0mg up to a total of 3mg
POISONING LARGE doses IV
RESP. DIFF. 1.0mg via nebulizer with beta-2 agonist for adults
PEDS DOSE:
0.02 mg / kg (minimum 0.1 mg)
SIDE EFFECTS:
Acute psychosis, vasodilation, dehydration, elevated surface temp, mydriasis.
Tachycardia or palpitations.
Mad as a hatter, red as a beet, dry as a bone, hot as a hare, blind as a bat
PRECAUTIONS:
Atropine has been reported to be harmful in some patients with AV block at the HIS-Purkinje level (type II AV block and third-degree AV block with a new wide-QRS complex).
May increase myocardial O2 demand in MI patients and aggravate CP
Too low a dose may cause paradoxical bradycardia
Exacerbation of glaucoma
Can cause acute urinary retention in males with enlarged prostate
Physostigmine reverses the effects of atropine and is used to treat atropine overdose
Worsens symptoms of myasthenia gravis